{"id":86093,"date":"2021-04-20T18:56:17","date_gmt":"2021-04-20T21:56:17","guid":{"rendered":"https:\/\/iclos.global\/eng\/?post_type=product&#038;p=86093"},"modified":"2021-04-22T13:10:59","modified_gmt":"2021-04-22T16:10:59","slug":"octanate","status":"publish","type":"product","link":"https:\/\/iclos.global\/eng\/producto\/octanate\/","title":{"rendered":"Octanate"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_class=\u00bbborro-en-producto\u00bb][vc_column width=\u00bb1\/1&#8243;][vc_column_text]<\/p>\n<h3>Principio activo: Factor VIII (FVIII)<br \/>\nPresentaciones: V\u00eda iv+sol+kit 500 Iu 10 ml X 1<\/h3>\n<p>&nbsp;<\/p>\n<h4><\/h4>\n<p><strong>Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)<\/strong><\/p>\n<p>Cuando se infunde en un paciente hemof\u00edlico, el factor VIII se une al factor de von Willebrand. El factor VIII activado act\u00faa como un cofactor para el factor IX activado, acelerando la conversi\u00f3n del factor X al factor X activado. El factor X activado convierte la protrombina a trombina la cual convierte el fibrin\u00f3geno en fibrina generando un co\u00e1gulo.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=\u00bb0&#8243; overlay_alpha=\u00bb50&#8243; gutter_size=\u00bb3&#8243; column_width_percent=\u00bb100&#8243; shift_y=\u00bb0&#8243; z_index=\u00bb0&#8243; el_class=\u00bbcatalogo-item\u00bb][vc_column width=\u00bb1\/1&#8243;][vc_row_inner][vc_column_inner width=\u00bb1\/1&#8243;][vc_empty_space empty_h=\u00bb0&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=\u00bb5\/6&#8243;][vc_column_text][\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/6&#8243;][vc_column_text]<img decoding=\"async\" class=\"alignnone wp-image-85422 size-full\" src=\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2020\/05\/logo-prod.png\" alt=\"\" width=\"128\" height=\"46\" \/>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<h3>Principio activo: Factor VIII (FVIII)<br \/>\nPresentaciones: V\u00eda iv+sol+kit 500 Iu 10 ml X 1<\/h3>\n<p>&nbsp;<\/p>\n<h4><\/h4>\n<p><strong>Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)<\/strong><\/p>\n<p>Cuando se infunde en un paciente hemof\u00edlico, el factor VIII se une al factor de von Willebrand. El factor VIII activado act\u00faa como un cofactor para el factor IX activado, acelerando la conversi\u00f3n del factor X al factor X activado. El factor X activado convierte la protrombina a trombina la cual convierte el fibrin\u00f3geno en fibrina generando un co\u00e1gulo.<\/p>\n<p><strong>Indicaciones terap\u00e9uticas<\/strong><\/p>\n<ul>\n<li>Tratamiento y prevenci\u00f3n de episodios hemorr\u00e1gicos en pacientes adultos y ni\u00f1os con hemofilia A.<\/li>\n<li>Tratamiento de inhibidores mediante Inducci\u00f3n de Tolerancia Inmune (ITI) en adultos y ni\u00f1os<\/li>\n<\/ul>\n<p><strong>Aprobaciones y pautas (FDA; EMA; ASCO; ESMO)<\/strong><\/p>\n<p>Factor VIII ha sido aprobado por EMA y FDA para las indicaciones anteriormente mencionadas.<\/p>\n<p><strong>Dosis y plan terap\u00e9utico<\/strong><\/p>\n<p>Hemofilia A: entre 20-40 Ul\/kg v\u00eda IV<br \/>\nUnidades requeridas = peso corporal (kg) x aumento del factor VIII deseado (%) (UI\/dl) x 0,5<br \/>\nAjustar la dosis y la frecuencia seg\u00fan el grado de hemorragia \/ tipo de procedimiento quir\u00fargico.<br \/>\nInducci\u00f3n de Tolerancia Inmune: entre 50-150 UI\/kg v\u00eda IV.<\/p>\n<p><em>Por m\u00e1s informaci\u00f3n ver la ficha t\u00e9cnica del producto.<\/em><\/p>\n","protected":false},"featured_media":86132,"template":"","meta":[],"product_cat":[125],"product_tag":[],"class_list":{"0":"post-86093","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-sin-categorizar","7":"pa_area-terapeutica-hemoderivados","8":"pa_nombre-octanate","9":"pa_principio-activo-factor-viii-fviii","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Octanate - ICLOS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/iclos.global\/eng\/producto\/octanate\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Octanate - ICLOS\" \/>\n<meta property=\"og:description\" content=\"Principio activo: Factor VIII (FVIII) Presentaciones: V\u00eda iv+sol+kit 500 Iu 10 ml X 1 &nbsp;  Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)  Cuando se infunde en un paciente hemof\u00edlico, el factor VIII se une al factor de von Willebrand. El factor VIII activado act\u00faa como un cofactor para el factor IX activado, acelerando la conversi\u00f3n del factor X al factor X activado. El factor X activado convierte la protrombina a trombina la cual convierte el fibrin\u00f3geno en fibrina generando un co\u00e1gulo.  Indicaciones terap\u00e9uticas   Tratamiento y prevenci\u00f3n de episodios hemorr\u00e1gicos en pacientes adultos y ni\u00f1os con hemofilia A.  Tratamiento de inhibidores mediante Inducci\u00f3n de Tolerancia Inmune (ITI) en adultos y ni\u00f1os  Aprobaciones y pautas (FDA; EMA; ASCO; ESMO)  Factor VIII ha sido aprobado por EMA y FDA para las indicaciones anteriormente mencionadas.  Dosis y plan terap\u00e9utico  Hemofilia A: entre 20-40 Ul\/kg v\u00eda IV Unidades requeridas = peso corporal (kg) x aumento del factor VIII deseado (%) (UI\/dl) x 0,5 Ajustar la dosis y la frecuencia seg\u00fan el grado de hemorragia \/ tipo de procedimiento quir\u00fargico. Inducci\u00f3n de Tolerancia Inmune: entre 50-150 UI\/kg v\u00eda IV.  Por m\u00e1s informaci\u00f3n ver la ficha t\u00e9cnica del producto.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/iclos.global\/eng\/producto\/octanate\/\" \/>\n<meta property=\"og:site_name\" content=\"ICLOS\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-22T16:10:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"200\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/\",\"url\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/\",\"name\":\"Octanate - ICLOS\",\"isPartOf\":{\"@id\":\"https:\/\/iclos.global\/eng\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\",\"datePublished\":\"2021-04-20T21:56:17+00:00\",\"dateModified\":\"2021-04-22T16:10:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/iclos.global\/eng\/producto\/octanate\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/#primaryimage\",\"url\":\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\",\"contentUrl\":\"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg\",\"width\":200,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/iclos.global\/eng\/producto\/octanate\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/iclos.global\/eng\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tienda\",\"item\":\"https:\/\/iclos.global\/eng\/tienda\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Octanate\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/iclos.global\/eng\/#website\",\"url\":\"https:\/\/iclos.global\/eng\/\",\"name\":\"MEGALABS\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/iclos.global\/eng\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Octanate - ICLOS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/iclos.global\/eng\/producto\/octanate\/","og_locale":"es_ES","og_type":"article","og_title":"Octanate - ICLOS","og_description":"Principio activo: Factor VIII (FVIII) Presentaciones: V\u00eda iv+sol+kit 500 Iu 10 ml X 1 &nbsp;  Mecanismo de acci\u00f3n y blancos moleculares (biol\u00f3gicos)  Cuando se infunde en un paciente hemof\u00edlico, el factor VIII se une al factor de von Willebrand. El factor VIII activado act\u00faa como un cofactor para el factor IX activado, acelerando la conversi\u00f3n del factor X al factor X activado. El factor X activado convierte la protrombina a trombina la cual convierte el fibrin\u00f3geno en fibrina generando un co\u00e1gulo.  Indicaciones terap\u00e9uticas   Tratamiento y prevenci\u00f3n de episodios hemorr\u00e1gicos en pacientes adultos y ni\u00f1os con hemofilia A.  Tratamiento de inhibidores mediante Inducci\u00f3n de Tolerancia Inmune (ITI) en adultos y ni\u00f1os  Aprobaciones y pautas (FDA; EMA; ASCO; ESMO)  Factor VIII ha sido aprobado por EMA y FDA para las indicaciones anteriormente mencionadas.  Dosis y plan terap\u00e9utico  Hemofilia A: entre 20-40 Ul\/kg v\u00eda IV Unidades requeridas = peso corporal (kg) x aumento del factor VIII deseado (%) (UI\/dl) x 0,5 Ajustar la dosis y la frecuencia seg\u00fan el grado de hemorragia \/ tipo de procedimiento quir\u00fargico. Inducci\u00f3n de Tolerancia Inmune: entre 50-150 UI\/kg v\u00eda IV.  Por m\u00e1s informaci\u00f3n ver la ficha t\u00e9cnica del producto.","og_url":"https:\/\/iclos.global\/eng\/producto\/octanate\/","og_site_name":"ICLOS","article_modified_time":"2021-04-22T16:10:59+00:00","og_image":[{"width":200,"height":200,"url":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/iclos.global\/eng\/producto\/octanate\/","url":"https:\/\/iclos.global\/eng\/producto\/octanate\/","name":"Octanate - ICLOS","isPartOf":{"@id":"https:\/\/iclos.global\/eng\/#website"},"primaryImageOfPage":{"@id":"https:\/\/iclos.global\/eng\/producto\/octanate\/#primaryimage"},"image":{"@id":"https:\/\/iclos.global\/eng\/producto\/octanate\/#primaryimage"},"thumbnailUrl":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","datePublished":"2021-04-20T21:56:17+00:00","dateModified":"2021-04-22T16:10:59+00:00","breadcrumb":{"@id":"https:\/\/iclos.global\/eng\/producto\/octanate\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/iclos.global\/eng\/producto\/octanate\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/iclos.global\/eng\/producto\/octanate\/#primaryimage","url":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","contentUrl":"https:\/\/iclos.global\/eng\/wp-content\/uploads\/2021\/04\/nada200.jpg","width":200,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/iclos.global\/eng\/producto\/octanate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/iclos.global\/eng\/"},{"@type":"ListItem","position":2,"name":"Tienda","item":"https:\/\/iclos.global\/eng\/tienda\/"},{"@type":"ListItem","position":3,"name":"Octanate"}]},{"@type":"WebSite","@id":"https:\/\/iclos.global\/eng\/#website","url":"https:\/\/iclos.global\/eng\/","name":"MEGALABS","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/iclos.global\/eng\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product\/86093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/media\/86132"}],"wp:attachment":[{"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/media?parent=86093"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product_cat?post=86093"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/iclos.global\/eng\/wp-json\/wp\/v2\/product_tag?post=86093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}